CLEVELAND, Oct. 12 /PRNewswire/ -- RSB Spine, LLC, today announced that the InterPlate(R) C-Ti has been cleared for a new indication. When reclassification of interbody fusion devices occurred in 2007, the C-Ti was the first system cleared by the U.S. Food and Drug Administration. With this most recent announcement, the C-Ti has now become the first interbody fusion device to be cleared as an anterior cervical plate as well.
RSB Spine Chief Executive Officer John A. Redmond said: "We are excited about this new clearance for a number of reasons. As the name implies, we have always been of the opinion that the InterPlate C-Ti can function as an interbody device or a cervical plate. It has the advantages of both without any of the drawbacks of either, so this indication is appropriate. The new indication for use also simplifies coding for our surgeons."
Robert S. Bray Jr., M.D., is the inventor of the InterPlate and has performed over 9,000 spine surgeries. He is the Founding Director and CEO of D.I.S.C. Sports and Spine Center, a state-of-the-art outpatient surgery center in Marina del Rey, CA. Dr. Bray said: "The RSB InterPlate C-Ti gives surgeons a number of options and the new classification allows the codes for surgery to match its true application. Considering our clinical experience thus far and the C-Ti's ease of use, it should be even more widely accepted." Dr. Bray has invented a number of other commercially successful medical devices.
RSB Spine is a privately held medical device company focused on developing innovative spinal implants with a focus on modular fusion products. News releases and other information on the company are available on the Internet at: http://www.rsbspine.com.
SOURCE RSB Spine, LLC
CONTACT: John A. Redmond, Chief Executive Officer of RSB Spine, LLC,
Web site: http://www.rsbspine.com/